Supportive care of patients diagnosed with high grade glioma and their carers in Australia.
Halkett, GKB
Berg, MN
Daudu, D
Dhillon, HM
Koh, E-S
Ownsworth, T
Lobb, E
Phillips, J
Langbecker, D
Agar, M
Hovey, E
Moorin, R
Nowak, AK
- Publisher:
- Springer
- Publication Type:
- Journal Article
- Citation:
- Journal of Neuro-Oncology, 2022, 157, (3), pp. 475-485
- Issue Date:
- 2022-05
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Halkett, GKB | |
dc.contributor.author | Berg, MN | |
dc.contributor.author | Daudu, D | |
dc.contributor.author | Dhillon, HM | |
dc.contributor.author | Koh, E-S | |
dc.contributor.author | Ownsworth, T | |
dc.contributor.author | Lobb, E | |
dc.contributor.author |
Phillips, J https://orcid.org/0000-0002-3691-8230 |
|
dc.contributor.author | Langbecker, D | |
dc.contributor.author |
Agar, M https://orcid.org/0000-0002-6756-6119 |
|
dc.contributor.author | Hovey, E | |
dc.contributor.author | Moorin, R | |
dc.contributor.author | Nowak, AK | |
dc.date.accessioned | 2022-09-30T03:57:03Z | |
dc.date.available | 2022-03-18 | |
dc.date.available | 2022-09-30T03:57:03Z | |
dc.date.issued | 2022-05 | |
dc.identifier.citation | Journal of Neuro-Oncology, 2022, 157, (3), pp. 475-485 | |
dc.identifier.issn | 0167-594X | |
dc.identifier.issn | 1573-7373 | |
dc.identifier.uri | http://hdl.handle.net/10453/162192 | |
dc.description.abstract | PURPOSE: This study aimed to: determine the supportive care available for Australian patients with High Grade Glioma (HGG) and their carers; identify service gaps; and inform changes needed to implement guidelines and Optimal Care Pathways. METHODS: This cross-sectional online survey recruited multidisciplinary health professionals (HPs) who were members of the Cooperative Trials Group for Neuro-Oncology involved in management of patients diagnosed with HGG in Australian hospitals. Descriptive statistics were calculated. Fisher's exact test was used to explore differences between groups. RESULTS: 42 complete responses were received. A majority of MDT meetings were attended by a: neurosurgeon, radiation oncologist, medical oncologist, radiologist, and care coordinator. Less than 10% reported attendance by a palliative care nurse; physiotherapist; neuropsychologist; or speech therapist. Most could access referral pathways to a cancer care coordinator (76%), neuropsychologist (78%), radiation oncology nurse (77%), or psycho-oncologist (73%), palliative care (93-100%) and mental health professionals (60-85%). However, few routinely referred to an exercise physiologist (10%), rehabilitation physician (22%), dietitian (22%) or speech therapist (28%). Similarly, routine referrals to specialist mental health services were not standard practice. Nearly all HPs (94%) reported HGG patients were advised to present to their GP for pre-existing conditions/comorbidities; however, most HPs took responsibility (≤ 36% referred to GP) for social issues, mental health, symptoms, cancer complications, and treatment side-effects. CONCLUSIONS: While certain services are accessible to HGG patients nationally, improvements are needed. Psychosocial support, specialist allied health, and primary care providers are not yet routinely integrated into the care of HGG patients and their carers despite these services being considered essential in clinical practice guidelines and optimal care pathways. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Springer | |
dc.relation.ispartof | Journal of Neuro-Oncology | |
dc.relation.isbasedon | 10.1007/s11060-022-03991-z | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1109 Neurosciences, 1112 Oncology and Carcinogenesis | |
dc.subject.classification | Oncology & Carcinogenesis | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Caregivers | |
dc.subject.mesh | Cross-Sectional Studies | |
dc.subject.mesh | Glioma | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Palliative Care | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Caregivers | |
dc.subject.mesh | Cross-Sectional Studies | |
dc.subject.mesh | Glioma | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Palliative Care | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Glioma | |
dc.subject.mesh | Palliative Care | |
dc.subject.mesh | Cross-Sectional Studies | |
dc.subject.mesh | Caregivers | |
dc.subject.mesh | Australia | |
dc.title | Supportive care of patients diagnosed with high grade glioma and their carers in Australia. | |
dc.type | Journal Article | |
utslib.citation.volume | 157 | |
utslib.location.activity | United States | |
utslib.for | 1109 Neurosciences | |
utslib.for | 1112 Oncology and Carcinogenesis | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Strength - CHT - Health Technologies | |
pubs.organisational-group | /University of Technology Sydney/Centre for Health Technologies (CHT) | |
utslib.copyright.status | open_access | * |
pubs.consider-herdc | false | |
dc.date.updated | 2022-09-30T03:57:00Z | |
pubs.issue | 3 | |
pubs.publication-status | Published | |
pubs.volume | 157 | |
utslib.citation.issue | 3 |
Abstract:
PURPOSE: This study aimed to: determine the supportive care available for Australian patients with High Grade Glioma (HGG) and their carers; identify service gaps; and inform changes needed to implement guidelines and Optimal Care Pathways. METHODS: This cross-sectional online survey recruited multidisciplinary health professionals (HPs) who were members of the Cooperative Trials Group for Neuro-Oncology involved in management of patients diagnosed with HGG in Australian hospitals. Descriptive statistics were calculated. Fisher's exact test was used to explore differences between groups. RESULTS: 42 complete responses were received. A majority of MDT meetings were attended by a: neurosurgeon, radiation oncologist, medical oncologist, radiologist, and care coordinator. Less than 10% reported attendance by a palliative care nurse; physiotherapist; neuropsychologist; or speech therapist. Most could access referral pathways to a cancer care coordinator (76%), neuropsychologist (78%), radiation oncology nurse (77%), or psycho-oncologist (73%), palliative care (93-100%) and mental health professionals (60-85%). However, few routinely referred to an exercise physiologist (10%), rehabilitation physician (22%), dietitian (22%) or speech therapist (28%). Similarly, routine referrals to specialist mental health services were not standard practice. Nearly all HPs (94%) reported HGG patients were advised to present to their GP for pre-existing conditions/comorbidities; however, most HPs took responsibility (≤ 36% referred to GP) for social issues, mental health, symptoms, cancer complications, and treatment side-effects. CONCLUSIONS: While certain services are accessible to HGG patients nationally, improvements are needed. Psychosocial support, specialist allied health, and primary care providers are not yet routinely integrated into the care of HGG patients and their carers despite these services being considered essential in clinical practice guidelines and optimal care pathways.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph